Sarcopenia in Acute Ischemic Stroke

The objective of this observational study is to determine the prevalence of sarcopenia inpatients aged 50 years and older with acute ischemic stroke, to characterize itstrajectory during the acute phase using instrumental verification andfunctional‐cognitive assessments, and to evaluate its impact on functional outcome atthree months. The main research question is:Is the presence of sarcopenia at admission associated with less favorable strokeoutcomes, including higher rates of complications and mortality?Participants receiving standard medical care for acute ischemic stroke will undergoextended functional assessment for sarcopenia, and a subset will additionally undergocognitive evaluation.